[HTML][HTML] SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Memory T cells induced by previous pathogens can shape susceptibility to, and the clinical
severity of, subsequent infections 1 . Little is known about the presence in humans of pre-…
severity of, subsequent infections 1 . Little is known about the presence in humans of pre-…
[HTML][HTML] Coronavirus disease 2019 (COVID-19): an evidence map of medical literature
Background Since the beginning of the COVID-19 outbreak in December 2019, a substantial
body of COVID-19 medical literature has been generated. As of June 2020, gaps and …
body of COVID-19 medical literature has been generated. As of June 2020, gaps and …
[HTML][HTML] Use of analgesics/antipyretics in the management of symptoms associated with COVID-19 vaccination
COVID-19 vaccines are effective and important to control the ongoing pandemic, but vaccine
reactogenicity may contribute to poor uptake. Analgesics or antipyretic medications are …
reactogenicity may contribute to poor uptake. Analgesics or antipyretic medications are …
Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus …
Objectives The aim of this study was to determine clinical outcomes of older patients with
coronavirus (COVID-19) who received a combination of vitamin D, magnesium, and vitamin B …
coronavirus (COVID-19) who received a combination of vitamin D, magnesium, and vitamin B …
[PDF][PDF] A dynamic immune response shapes COVID-19 progression
The inflammatory response to SARS-coronavirus-2 (SARS-CoV-2) infection is thought to
underpin COVID-19 pathogenesis. We conducted daily transcriptomic profiling of three COVID-…
underpin COVID-19 pathogenesis. We conducted daily transcriptomic profiling of three COVID-…
[HTML][HTML] SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity
… We also analyzed the expression of CD45RA and CCR7: the majority of the T cells were
effector memory T cells (TEM; CD4 + , <90%; CD8 + , <60%) or terminally differentiated …
effector memory T cells (TEM; CD4 + , <90%; CD8 + , <60%) or terminally differentiated …
Current status of silica-based nanoparticles as therapeutics and its potential as therapies against viruses
DJH Tng, JGH Low - Antiviral Research, 2023 - Elsevier
In the past decade, interest in nanoparticles for clinical indications has been steadily gaining
traction. Most recently, Lipid Nanoparticles (LNP) have been used successfully to construct …
traction. Most recently, Lipid Nanoparticles (LNP) have been used successfully to construct …
Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19
We read with great interest the article published by Zuo et al, which highlighted the presence
of SARS-CoV-2 RNA in stool samples during active and convalescence phases of COVID-…
of SARS-CoV-2 RNA in stool samples during active and convalescence phases of COVID-…
[HTML][HTML] Critically ill COVID‐19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability
CW Tan, JGH Low, WH Wong, YY Chua… - American journal of …, 2020 - ncbi.nlm.nih.gov
1. Smeeth L, Cook C, Thomas S, Hall AJ, Hubbard R, Vallance P. Risk of deep vein thrombosis
and pulmonary embolism after acute infection in a community setting. Lancet. 2006; 367 (…
and pulmonary embolism after acute infection in a community setting. Lancet. 2006; 367 (…
[HTML][HTML] Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
Background Given the unceasing worldwide surge in COVID-19 cases, there is an imperative
need to develop highly specific and sensitive serology assays to define exposure to …
need to develop highly specific and sensitive serology assays to define exposure to …